HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews (03/07)

Executive Summary

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: Do-It-Yourself Dermatology, features profiles of Therative and Xthetix. Plus these Start-Ups Across Health Care: iCardiac Technologies, Jenken Biosciences, Neovasc Medical, and Syntaxin.

You may also be interested in...

Therative Inc.

With one look at the technology and some research into the acne market, Therative came to a quick contrarian conclusion: to sell its acne treatment device directly to the 45 million Americans who need it, not to the thousands of dermatologists who treat only 20% of those millions. And so Therative entered the home-use aesthetic market.

Neovasc Medical Ltd.

Neovasc Medical intends to provide a solution for the millions of patients that can't benefit from bypass, PCIs and other traditional revascularization techniques. It has developed a minimally invasive procedure in which a stent inserted percutaneously into the coronary sinus partially restricts the flow of blood exiting into the arteries. The blood flows backwards into the heart, retroperfusing the tissue and reducing symptoms of ischemia.

Do-It-Yourself Dermatology

As venture capitalists begin counting cosmetics and aesthetics companies as part of their portfolios, they're also migrating toward investing in consumer-oriented companies including those that make aesthetic devices to be used in the home.

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts